Envista Holdings Corp (FRA:0HV)
€ 18.9 -0.6 (-3.08%) Market Cap: 3.33 Bil Enterprise Value: 3.88 Bil PE Ratio: 0 PB Ratio: 1.16 GF Score: 68/100

Envista Holdings Corp at Wolfe Research Healthcare Conference (Virtual) Transcript

Nov 18, 2020 / 03:30PM GMT
Release Date Price: €24.2
Stephen Christopher Beuchaw
Wolfe Research, LLC - Director of Equity Research

Hi, everybody. Thanks for jumping on. Steve Beuchaw here from Wolfe Research. We're doing the virtual thing, of course, here with our conference here in year 2. As you may know, I'm 1 of 5 Wolfe analysts, and we're really happy -- in health care that is. And we're really happy about the lineup that we have this year as we've gone to a 2-day setup. And we're having a lot of fun with it.

Our first company within my broader coverage here at the conference is Envista, which has been a fascinating story in terms of the way that they've managed through 2020. We have the full brain trust with us. We have Amir Aghdaei, the CEO; Howard Yu, CFO of company; and John Bedford, who runs IR and has a dual mandate, including some FP&A as well.

So thanks, everybody, for being here and for managing to pull 3 laptops together into a single conference room to accommodate our software. Really appreciate that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot